Weather Disasters Threaten U.S. Drug Supply Chain Resilience

S. pharmaceutical supply chains: increasing weather disasters and climate volatility are creating systemic disruption risks across production, storage, and distribution networks. The study underscores that while individual weather events may cause temporary shortages, the frequency and unpredictability of extreme weather—combined with the just-in-time nature of modern drug distribution—creates compounding risks that threaten medication availability at scale.

For supply chain professionals, this research signals a critical need to reassess geographic concentration of pharmaceutical manufacturing and warehousing, particularly around climate-vulnerable regions. Cold-chain logistics, already operating on razor-thin margins with limited redundancy, face particular exposure to power outages, temperature excursions, and infrastructure damage during severe weather events. Organizations must now incorporate climate resilience metrics into supplier risk assessments and facility location decisions.

The implications extend beyond operational continuity to strategic planning. Companies relying on single-source or geographically concentrated suppliers for active pharmaceutical ingredients (APIs) and finished goods face elevated regulatory and reputational risk if weather-driven shortages occur. Proactive network redesign, dual sourcing, and distributed buffer inventory strategies are transitioning from "nice-to-have" to essential components of pharmaceutical supply chain strategy.